Profiling circulating and urinary bile acids in patients with biliary obstruction before and after biliary stenting.
about
Lithocholic acid feeding results in direct hepato-toxicity independent of neutrophil function in miceThe Impact of Sterile Inflammation in Acute Liver Injury.Glycodeoxycholic acid levels as prognostic biomarker in acetaminophen-induced acute liver failure patientsMitofusin 2 protects hepatocyte mitochondrial function from damage induced by GCDCA.Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis.Hepatic expression of detoxification enzymes is decreased in human obstructive cholestasis due to gallstone biliary obstructionExpression of hepatic Fibroblast Growth Factor 19 is enhanced in Primary Biliary Cirrhosis and correlates with severity of the diseaseTranslational biomarkers of acetaminophen-induced acute liver injuryTargeted profiling of circulating and hepatic bile acids in human, mouse, and rat using a UPLC-MRM-MS-validated method.Novel insight into mechanisms of cholestatic liver injury.Bile Acid-Induced Toxicity in HepaRG Cells Recapitulates the Response in Primary Human HepatocytesSurface Tension Triggered Wetting and Point of Care Sensor DesignDecreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease.Pleiotropic roles of bile acids in metabolism.Altered Bile Acid Metabolome in Patients with Nonalcoholic SteatohepatitisTherapeutic targets for cholestatic liver injurySerum Autotaxin is a Marker of the Severity of Liver Injury and Overall Survival in Patients with Cholestatic Liver Diseases.Role of glucuronidation for hepatic detoxification and urinary elimination of toxic bile acids during biliary obstruction.Heterozygous Inactivation of the Nuclear Receptor PXR/NR1I2 in a Patient With Anabolic Steroid-Induced Intrahepatic Cholestasis.Plasma biomarkers of liver injury and inflammation demonstrate a lack of apoptosis during obstructive cholestasis in miceDevelopment of blood biomarkers for drug-induced liver injury: an evaluation of their potential for risk assessment and diagnostics.SIRT1/PGC-1α signaling protects hepatocytes against mitochondrial oxidative stress induced by bile acids.Urinary bile acids as biomarkers for liver diseases II. Signature profiles in patients.Evaluation of serum bile acid profiles as biomarkers of liver injury in rodents.Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis.Reprogramming of pro-inflammatory human macrophages to an anti-inflammatory phenotype by bile acids.The Role of Inflammation in the Mechanisms of Bile Acid-Induced Liver Damage.Selective and sensitive quantification of the cytochrome P450 3A4 protein in human liver homogenates through multiple reaction monitoring mass spectrometry.Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans.N-3 Polyunsaturated Fatty Acids Stimulate Bile Acid Detoxification in Human Cell Models.Urinary Elimination of Bile Acid Glucuronides under Severe Cholestatic Situations: Contribution of Hepatic and Renal Glucuronidation Reactions.Can BSEP Inhibition Testing In Drug Discovery And Development Reduce Liver Injury Risk? - An International Transporter Consortium PerspectiveYinchenhao Decoction Alleviates Liver Fibrosis by Regulating Bile Acid Metabolism and TGF-β/Smad/ERK Signalling Pathway
P2860
Q33754301-B31CE8A0-39DC-475A-A495-0C6877C885C6Q33847610-E945D407-96EA-4B64-9D74-CE25BBA68041Q34606009-E0E94323-415E-4317-A01B-3D5E8A3BBAB0Q34766553-D37B9442-A3C4-4903-94B1-962F263D56C7Q35181443-685C4AE3-3D10-4722-808F-05242B431CE1Q35583781-FA5694B9-6E93-4D94-8C8A-AB60D1126E56Q35979451-E2D424AD-2A26-4428-B77E-7D2BE7EF32CDQ36001451-E402D81A-732B-4E69-8991-746530BBDC3DQ36213935-B07D27E8-BB96-4167-A87E-D04789CF7173Q36285749-C1B36CE3-4FC8-4E27-9B6C-71BEC370CC8FQ36464118-E3714C6A-13B9-44E6-85A6-D2F0FD648E14Q36682908-D91CAD8C-532B-465E-8B65-051C4CE564BCQ36769334-6BE31B67-7788-40A1-9748-53DDB90B279CQ36843966-5F2399C6-A268-41BB-B8C6-6E364F36EB49Q36893921-00362614-2407-4DA5-813A-8350D20E4378Q36960966-7B10C054-A2B5-4DDA-BAEB-8110DEF2563BQ37163154-1FAEE53E-F53B-4C49-88EF-136F07E9C17DQ37309043-4C21B6D7-AA98-41D4-8810-A82F90469929Q37358971-357C1EB6-D2C8-4D73-A2BE-B274595B3E79Q37387193-4B249AB7-44B1-4261-B33F-B4697E1AD0DAQ38122649-F15226BE-4024-4F9B-8570-A59144D9A1D5Q38897577-4B16C270-DDA6-45F2-9DE6-C5F9846B9E7AQ42703776-284F85E0-FD5B-4C83-BF22-92E5E344D950Q42709123-4FF483A8-3CDB-4C97-98DE-860679049DA1Q46933007-644FDFC3-235A-43A6-AC9B-8AA2DB4423F7Q47555746-C8640611-137D-47C4-A822-AF34D46C8680Q50866973-1E59B390-83F2-4BA0-B9ED-00BAB193105BQ51501246-BB9E7EAF-DD8B-411F-A2EE-1051164AFA13Q52669418-1F36D544-1E58-4132-AA06-FDBD5DD17487Q55020611-60AD6527-5EFF-408F-B2C7-B9B6D6AC6200Q55037290-F8BA34AE-989B-485A-81B9-990C4F3158CFQ57111135-20286C85-1315-46B9-B881-50CBC39FA88CQ58603577-EF1CCF51-D37B-4A69-B0E2-24F0A4D3BD82
P2860
Profiling circulating and urinary bile acids in patients with biliary obstruction before and after biliary stenting.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Profiling circulating and urin ...... re and after biliary stenting.
@ast
Profiling circulating and urin ...... re and after biliary stenting.
@en
type
label
Profiling circulating and urin ...... re and after biliary stenting.
@ast
Profiling circulating and urin ...... re and after biliary stenting.
@en
prefLabel
Profiling circulating and urin ...... re and after biliary stenting.
@ast
Profiling circulating and urin ...... re and after biliary stenting.
@en
P2093
P2860
P1433
P1476
Profiling circulating and urin ...... re and after biliary stenting.
@en
P2093
Andrzej Białek
Olivier Barbier
Patrick Caron
Robert J Straka
P2860
P304
P356
10.1371/JOURNAL.PONE.0022094
P407
P577
2011-07-08T00:00:00Z